Prelude Capital Management, LLC Ibere Pharmaceuticals Transaction History

Prelude Capital Management, LLC

  • $1.57 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$9.77 - $9.84 $97,700 - $98,400
-10,000 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$9.68 - $9.77 $35,177 - $35,504
-3,634 Reduced 26.65%
10,000 $97,000
Q3 2021

Nov 15, 2021
BUY
$9.61 - $9.78 $34,922 - $35,540
3,634 Added 36.34%
13,634 $133,000
Q2 2021

Aug 16, 2021
BUY
$9.65 - $9.95 $96,500 - $99,500
10,000 New
10,000 $97,000

Others Institutions Holding IBER

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About IBERE PHARMACEUTICALS

IBER Quotes by TradingView
  • Ticker IBER
  • Exchange NYSE
  • Sector Financial Services
  • Industry Shell Companies
  • Shares Outstandng 13,800,000
  • Description
  • Ibere Pharmaceuticals does not have significant operations. It focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses. The company was incorporated in 2020 and is based in Philadelphia, Pennsylvania.
More about IBER
Track This Portfolio

Track Prelude Capital Management, LLC Portfolio

Follow Prelude Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email